Search company, investor...

TO Pharma

topharm.com

About TO Pharma

TO Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics based on its proprietary cannabinoid product platform in a number of FDA-regulated clinical indications and in select OTC markets.

Headquarters Location

2150 Cabot Blvd West Suite B

Langhorne, Pennsylvania, 19047,

United States

215-702-8550

Missing: TO Pharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: TO Pharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing TO Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

TO Pharma is included in 1 Expert Collection, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

TO Pharma Patents

TO Pharma has filed 4 patents.

The 3 most popular patent topics include:

  • Cannabinoids
  • Designer drugs
  • Phenols
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/28/2017

Cannabinoids, Designer drugs, Inflammations, Phenols, Autoimmune diseases

Application

Application Date

3/28/2017

Grant Date

Title

Related Topics

Cannabinoids, Designer drugs, Inflammations, Phenols, Autoimmune diseases

Status

Application

Latest TO Pharma News

Biden's Pick for Top NIH Post Has Deep Ties to Pharma - 'That Is How Agencies Are Captured'

May 18, 2023

| 17 May 2023 | Joe Biden this week nominated cancer specialist Dr. Monica Bertagnolli for director of the National Institutes of Health (NIH) -- a move that has already generated controversy because of Bertagnolli's longstanding financial ties to Pfizer and other pharmaceutical companies. Bertagnolli is director of the National Cancer Institute (NCI), the largest of the 19 institutes and seven centers under the aegis of the NIH... Under Bertagnolli's leadership, the Alliance for Clinical Trials in Oncology has received more than $323 million in funding from Pfizer and other Big Pharma firms, according to Open Payments data revealed by The Daily Signal and The Heritage Foundation's Oversight Project. In a series of tweets, Robert F. Kennedy, Jr., Children's Health Defense chairman on leave and Democratic candidate for president in 2024, criticized Bertagnolli's nomination. "The White House left the Pfizer connection out of its announcement of the nomination. Does this mean Dr. Bertagnolli is personally corrupt? Not at all. But it does mean that she will probably represent the viewpoints and priorities of the pharmaceutical industry. That is how agencies are captured," Kennedy wrote .

TO Pharma Frequently Asked Questions (FAQ)

  • Where is TO Pharma's headquarters?

    TO Pharma's headquarters is located at 2150 Cabot Blvd West, Langhorne.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.